Non-Drowsy Sinutab (Pseudoephedrine Hydrochloride, Paracetamol)

Pseudoephedrine Hydrochloride, the active ingredient in Non-Drowsy Sinutab, is a sympathomimetic decongestant presented as an oral tablet formulation for oral use. It relieves nasal congestion and, together with paracetamol, addresses headache, fever and minor aches in adults and adolescents.

GNH USA supplies Non-Drowsy Sinutab as a licensed, GDP‑compliant international pharmaceutical supplier, ensuring quality and regulatory compliance while serving hospitals, pharmacies and clinics worldwide. Our distribution network spans Europe, Asia, Africa and the Americas, providing reliable access to essential OTC medicines.

Non-Drowsy Sinutab, combining a decongestant and an analgesic, is used to treat common cold and flu‑related symptoms.

- Nasal congestion: reduction of swollen nasal passages for easier breathing. - Headache: alleviation of tension‑type or sinus‑related head pain. - Fever: lowering of elevated body temperature associated with viral infections. - Minor aches and pains: relief of muscle or joint discomfort accompanying cold or flu.

Non-Drowsy Sinutab may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Nervousness: feeling of restlessness or jitteriness. - Dry mouth: reduced salivation leading to throat discomfort. - Palpitations: awareness of heartbeat acceleration. - Nausea: mild stomach upset. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Hypertension: significant increase in blood pressure. - Arrhythmia: irregular heart rhythm that may require medical attention. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Liver injury: rare but possible elevation of liver enzymes. - Cardiovascular events: chest pain or myocardial infarction in susceptible individuals.

Before using Non-Drowsy Sinutab, consider the following safety measures.

- Assess cardiovascular status: check blood pressure and heart disease history. - Avoid use with MAO inhibitors: wait at least 14 days after discontinuation. - Limit duration: do not exceed the recommended treatment period, typically 3‑5 days. - Monitor liver function: caution in patients with existing liver disease. - Store at ambient temperature: keep in the original pack, protect from moisture.

Non-Drowsy Sinutab can interact with other medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - MAO inhibitors (e.g., phenelzine): risk of hypertensive crisis. - Tricyclic antidepressants: may amplify cardiovascular stimulation. - Certain antihypertensives: can diminish blood‑pressure‑lowering effect.

Moderate Interactions (Monitor Closely):\n- CYP2D6 inhibitors (e.g., fluoxetine): may increase pseudoephedrine levels. - Other paracetamol‑containing products: risk of overdose. - Diuretics: may enhance hypotensive response when combined with decongestant.